Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Clinical Trial to Evaluate Danoprevir Sodium Tablets Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection

NCT04345276 is registered in ClinicalTrials.gov with Huoshenshan Hospital as lead sponsor.

NCT NCT04345276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04345276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Clinical Trial to Evaluate Danoprevir Sodium Tablets Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection
Lead sponsor
Huoshenshan Hospital
Phase
Phase 4
Overall status
Completed
Start date
March 18, 2020
Completion date
April 15, 2020
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19